BACKEER and Netalis Medical have won the Women’s Health × EmbryoNet-AI Startup Competition, an international initiative designed to accelerate the...
Hera Biotech is developing the world’s first molecular, cell-based test for diagnosing and staging endometriosis
The research could help clinicians better predict patient response to existing medicines
Compared to other existing long-acting forms, contraceptive microneedle array patches can be self-administered
KindInstitute is hoped to help participating specialists to provide assistance in fertility practices nationwide
Maternal and newborn deaths are still a major public health problem in Kenya
Biorithm is developing a remote maternal-foetal care platform to help clinicians identify signs of pregnancy complications
New mums in England will benefit from personalised postnatal care to support their physical and mental health
The group is comprised of professionals at the forefront of reproductive medicine, artificial intelligence and global healthcare
Fezolinetant could potentially benefit hundreds of thousands of women approaching menopause
The test aims to help women with polycystic ovary syndrome and thyroid issues understand their reproductive health
By Anna Butterworth, founder and managing director at Ultra Violet
An efficient and reliable hosting solution is critical for businesses of all sizes. VPS hosting is a solid alternative to the less scalable shared hosting and...
The device is hoped to help women identify symptoms that could be signs of common female health conditions
TMRW's automated platform is hoped to help fertility clinics reduce the risk of specimen mix-up, error and loss
The project is supported by top researchers and aims to leverage Clue’s data for new insights
The acquisition is hoped to help Somedays improve the range of period care products available on the market
Experts in UX design and product strategy from Guidea will work with the 2024 Femovate companies to help them grow and develop
A HFEA report showed funding decreased most among Black patients, from 60 per cent in 2019 to 41 per cent in 2021
Freya Biosciences aims to address immune drivers underlying a range of reproductive system conditions
A new study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive
